Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Return on Sales (2016 - 2018)

Historic Return on Sales for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q4 2018 value amounting to 3.27%.

  • Armata Pharmaceuticals' Return on Sales rose 1208700.0% to 3.27% in Q4 2018 from the same period last year, while for Dec 2018 it was 7.61%, marking a year-over-year increase of 1202400.0%. This contributed to the annual value of 9.55% for FY2024, which is 323200.0% up from last year.
  • Armata Pharmaceuticals' Return on Sales amounted to 3.27% in Q4 2018, which was up 1208700.0% from 9.03% recorded in Q3 2018.
  • Armata Pharmaceuticals' 5-year Return on Sales high stood at 11.27% for Q2 2018, and its period low was 457.09% during Q4 2016.
  • In the last 5 years, Armata Pharmaceuticals' Return on Sales had a median value of 37.25% in 2014 and averaged 75.22%.
  • Its Return on Sales has fluctuated over the past 5 years, first skyrocketed by 7325500bps in 2014, then tumbled by -4346900bps in 2016.
  • Quarter analysis of 5 years shows Armata Pharmaceuticals' Return on Sales stood at 25.71% in 2014, then rose by 13bps to 22.4% in 2015, then crashed by -1941bps to 457.09% in 2016, then surged by 74bps to 117.6% in 2017, then surged by 103bps to 3.27% in 2018.
  • Its Return on Sales was 3.27% in Q4 2018, compared to 9.03% in Q3 2018 and 11.27% in Q2 2018.